Birchtech Corp. (BCHT) is a specialty activated-carbon technology company serving air and water purification markets. Its air business, anchored by Sorbent Enhancement Additive (SEA®) technology for mercury capture at coal-fired power plants, has historically generated most revenue, while a newer water-treatment platform targeting PFAS and PFOS contaminants (harmful "forever chemicals") represents the company's primary growth initiative. Because prior quarters were shaped by one-time licensing fees, investors closely watch underlying product revenue to gauge the durability of the core business. The quarter also carries strategic weight: management is converting licensed utilities into recurring supply customers and advancing a Carbon Rejuvenation® reactivation facility. With a $78 million patent judgment under appeal, this report offers a read on both near-term profitability and the company's liquidity runway for its water expansion. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Birchtech reported total third quarter 2026 revenue of $5.5 million, down from $7.4 million in the year-ago quarter. The decline reflected $2.6 million in one-time up-front license fees recognized in the third quarter of 2025, with no comparable transactions this year. Excluding that effect, product revenue increased 15.7% to $5.5 million from $4.7 million, driven by a favorable mix of plants running, higher coal demand tied to more extreme weather and higher natural gas prices, and the company's first recognized water-treatment sales.
Gross profit was $1.6 million, or 29.9% of revenue, down from $4.0 million, or 54.8% of revenue, a year earlier, primarily due to the absence of higher-margin licensing revenue. SG&A expenses fell 35% to $1.8 million, reflecting lower legal costs versus the prior-year period. Research and development (R&D) spending held roughly flat at $0.5 million.
The company posted a net loss of $0.3 million, or $0.01 per basic and diluted share, versus net income of $0.8 million, or $0.04 per share, in the third quarter of 2025. Adjusted EBITDA was a loss of $0.5 million, compared with positive $1.0 million a year ago. Birchtech closed the quarter with $10.8 million in cash and no debt.
Investor focus around this report centered less on the headline revenue decline and more on the durability of product sales and the progress of the water strategy. Because the prior-year quarter benefited from a one-time licensing windfall, many market participants anticipated a lower top-line comparison; the 15.7% product-revenue gain and first water sales were viewed as signs of momentum in the core business. Sentiment also remains tied to the appeal of the $78 million judgment, where post-judgment interest continues to accrue, and to management's ability to convert licensed utilities into recurring supply customers. The company's $10.8 million cash position and debt-free balance sheet reduced liquidity concerns heading into 2027, while the $5.0 million share-repurchase program signaled management's confidence in long-term value.
Looking ahead, investors will watch several catalysts tied to Birchtech's air-to-water transition. In the air business, the priority is converting licensed coal-fired utilities into recurring SEA® supply customers. Management expects product-supply revenue to increase in the second half of 2026, supported by a stable U.S. coal market and elevated natural gas prices.
In water, the company is advancing its first Carbon Rejuvenation® reactivation facility and has signed a new granular activated carbon (GAC) agreement intended to accelerate revenue beginning in early 2027 with no capital spending on Birchtech's part for initial supply. Progress on offtake discussions with prospective utility partners and the expansion of its Analytical Design Centers will be key indicators of commercial traction.
The legal front remains a swing factor. Birchtech has filed its appellee brief asking the Federal Circuit to affirm the roughly $78 million final judgment in full, with post-judgment interest accruing during the appeal. Any ruling, settlement, or collection milestone could materially affect the balance sheet and funding for growth. Investors should also monitor gross margins as the revenue mix shifts from higher-margin licensing to product sales, along with cost discipline as the company scales its water platform.
I often turn to Tickeron’s AI Screener when evaluating smaller names like this one. It helps me quickly filter peers by fundamentals, technical patterns, and AI signals, which gives me a clearer sense of where Birchtech stands relative to the broader sector without spending hours on manual screens. The tool has become a regular part of how I cross-check ideas before diving deeper into filings or conference calls.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
BCHT moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 30 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BCHT as a result. In 78 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.
The 10-day moving average for BCHT crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BCHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BCHT entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BCHT's RSI Indicator exited the oversold zone, 37 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for BCHT just turned positive on November 09, 2026. Looking at past instances where BCHT's MACD turned positive, the stock continued to rise in 34 of 46 cases over the following month. The odds of a continued upward trend are 74%.
Following a +11.50% 3-day Advance, the price is estimated to grow further. Considering data from situations where BCHT advanced for three days, in 143 of 189 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
BCHT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.711) is normal, around the industry mean (10.189). P/E Ratio (-6.765) is within average values for comparable stocks, (-16.372). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.975). Dividend Yield (0.000) settles around the average of (0.050) among similar stocks. P/S Ratio (1.812) is also within normal values, averaging (251.106).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. BCHT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BCHT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry IndustrialSpecialties